Merit Financial Group, LLC

Position in MRNA — Moderna, Inc.

CIK 1621225 ALPHARETTA, GA

Position in MRNA

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$1,765,104

+$1,509,317 QoQ

Shares Held

25,205

+1070.1% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#232

of 777 holders

Holding Since

Jun 2021

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Merit Financial Group, LLC holds $38,062,980 across 57 Biotechnology names. MRNA ranks #5 (4.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	12,218	$6,069,041
2	INCY	Incyte Corp	50,561	$5,731,591
3	EXEL	Exelixis, Inc.	84,634	$4,604,933
4	REGN	Regeneron Pharmaceuticals, Inc.	3,333	$2,078,255
5	MRNA	Moderna, Inc. This page	25,205	$1,765,104
6	JAZZ	Jazz Pharmaceuticals plc	5,380	$1,296,414
7	BMRN	Biomarin Pharmaceutical Inc	20,198	$1,155,727
8	CORT	Corcept Therapeutics Inc	11,908	$1,035,397

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,765,104	25,205	+1070.1%	Shares	Other	2026-07-20
2024-06-30	$255,787	2,154	-27.9%	Shares	Sole	2024-08-13
2024-03-31	$318,188	2,986	-10.6%	Shares	Sole	2024-05-06
2023-12-31	$332,262	3,341	-19.1%	Shares	Sole	2024-02-06
2023-09-30	$426,587	4,130	+2.3%	Shares	Sole	2023-11-07
2023-06-30	$490,495	4,037	+46.5%	Shares	Sole	2023-08-01
2023-03-31	$423,112	2,755	-78.3%	Shares	Sole	2023-04-24
2022-12-31	$2,277,401	12,679	-2.3%	Shares	Sole	2023-01-13
2022-09-30	$1,533,820	12,971	-17.9%	Shares	Sole	2022-10-31
2022-06-30	$2,257,315	15,802	+655.7%	Shares	Sole	2022-08-08
2022-03-31	$360,195	2,091	+60.8%	Shares	Sole	2022-05-13
2021-12-31	$330,174	1,300	+15.0%	Shares	Sole	2022-02-14
2021-09-30	$434,891	1,130	+19.6%	Shares	Sole	2021-10-27
2021-06-30	$222,056	945	—	Shares	Sole	2021-08-16
No filing history on record for this holder in this stock.